Emil T. Kuriakose

Corporate Officer/Principal bei TERNS PHARMACEUTICALS, INC.

Vermögen: 272 684 $ am 30.04.2024

44 Jahre

Health Technology

Consumer Services

Aktive Positionen von Emil T. Kuriakose

Unternehmen	Position	Beginn	Ende
TERNS PHARMACEUTICALS, INC.	Corporate Officer/Principal	01.05.2023	-

Unternehmen	Position	Beginn	Ende
Novartis Oncology, Inc. Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.	Technik-/Wissenschafts-/F&E-Leiter	01.07.2013	01.01.2016
CALITHERA BIOSCIENCES, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.08.2017	-

New York University	Undergraduate Degree
Stony Brook University School of Medicine	Doctorate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Health Technology	4
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
CALITHERA BIOSCIENCES, INC.	Health Technology
TERNS PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	1
Novartis Oncology, Inc. Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.	Health Technology